← Back
$GALT All transactions

GALECTIN THERAPEUTICS INC

M 10b5-1 Plan

$ Value

$0

Shares

200

Price

$0

Filed

Nov 7

Insider

Name

CALLICUTT JACK W

Title

Chief Financial Officer

CIK

0001266773

Roles

Officer

Transaction Details

Transaction Date

2025-11-05

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

39,566

Footnotes

The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025. | The options vested as follows: 25% on each of June 30, 2022, December 31, 2022, June 30, 2023, and December 31, 2023. | The options vested as follows: 25% on each of June 30, 2023, December 31, 2023, June 30, 2024, and December 31, 2024. | The options vested as follows: 25% on each of June 30, 2024, December 31, 2024, and June 30, 2025, with 25% scheduled to vest on December 31, 2025.

Filing Info

Accession No.

0001133416-25-000047

Form Type

4

Issuer CIK

0001133416

CALLICUTT JACK W's History

Date Ticker Type Value
2026-01-16 GALT A $0
2026-01-16 GALT A $0
2026-01-06 GALT $75K
2026-01-05 GALT $100K
2026-01-02 GALT M $0
2026-01-02 GALT $58K
2026-01-01 GALT M $0
2025-11-18 GALT M $56K
2025-11-18 GALT $175K
2025-11-18 GALT M $20K

Other Insiders at GALT (90d)

Insider Bought Sold Last
ELDRED KARY $810 2026-02-06
Brem Henry 2026-03-12